share_log

Embecta Analyst Ratings

Benzinga Analyst Ratings ·  Jan 6, 2023 08:57
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/06/2023 11.38% Morgan Stanley → $28 Downgrades Equal-Weight → Underweight
12/21/2022 23.31% Morgan Stanley $33 → $31 Maintains Equal-Weight
10/11/2022 31.26% Morgan Stanley $36 → $33 Maintains Equal-Weight
09/08/2022 BTIG Initiates Coverage On → Neutral
08/16/2022 43.2% Morgan Stanley $33 → $36 Maintains Equal-Weight
08/01/2022 31.26% Morgan Stanley → $33 Initiates Coverage On → Equal-Weight
06/21/2022 -0.56% B of A Securities → $25 Initiates Coverage On → Underperform

What is the target price for Embecta (EMBC)?

The latest price target for Embecta (NASDAQ: EMBC) was reported by Morgan Stanley on January 6, 2023. The analyst firm set a price target for $28.00 expecting EMBC to rise to within 12 months (a possible 11.38% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Embecta (EMBC)?

The latest analyst rating for Embecta (NASDAQ: EMBC) was provided by Morgan Stanley, and Embecta downgraded their underweight rating.

When is the next analyst rating going to be posted or updated for Embecta (EMBC)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Embecta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Embecta was filed on January 6, 2023 so you should expect the next rating to be made available sometime around January 6, 2024.

Is the Analyst Rating Embecta (EMBC) correct?

While ratings are subjective and will change, the latest Embecta (EMBC) rating was a downgraded with a price target of $0.00 to $28.00. The current price Embecta (EMBC) is trading at is $25.14, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment